trovafloxacin has been researched along with ro13-9904 in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (50.00) | 18.2507 |
| 2000's | 6 (42.86) | 29.6817 |
| 2010's | 1 (7.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hickey, SM; McCracken, GH; París, MM; Shelton, S; Trujillo, M | 1 |
| Chow, LL; Kim, YS; Liu, Q; Täuber, MG | 1 |
| Brück, W; Fischer, FR; Nau, R; Schmidt, H; Stringaris, AK; Stuertz, K; Zysk, G | 1 |
| Nicolau, DP; Nightingale, CH; Quintiliani, R; Tessier, PR | 1 |
| Gentry, MJ; Olsen, KM; Preheim, LC; Snitily, MU; Yue, M | 1 |
| Appelbaum, PC; Hoellman, DB; Jacobs, MR; Lin, G | 1 |
| Eiffert, H; Mäder, M; Nau, R; Schmidt, H; Stuertz, K; Trostdorf, F | 1 |
| Acosta, F; Cottagnoud, M; Cottagnoud, P; Neftel, K; Täuber, MG | 1 |
| Arora, H; Eckert, S; Johann-Liang, R; Noel, GJ; Purswani, M | 1 |
| Cortés Sanchez, R; García Alberola, A; Gómez Gómez, J; López Fornas, F; Martínez García, F; Pérez Salmeron, J; Roldán Conesa, D; Ruíz Gómez, J; Valdés Chávarri, M | 1 |
| Arguedas, AG; Arrieta, AC; Bradley, J; Falleiros-Carvalho, LH; Feris, JM; Frenck, RW; Hussey, GD; Klugman, KP; Marques, SR; McCoig, C; McCracken, GH; Pancorbo, S; Sáez-Llorens, X; Vargas, SL; Wald, ER | 1 |
| Nathan, BR; Scheld, WM | 1 |
| Gentry-Nielsen, MJ; Olsen, KM; Preheim, LC; Snitily, MU; Yue, M | 1 |
| Lenzer, J | 1 |
1 trial(s) available for trovafloxacin and ro13-9904
| Article | Year |
|---|---|
Quinolone treatment for pediatric bacterial meningitis: a comparative study of trovafloxacin and ceftriaxone with or without vancomycin.
Topics: Anti-Infective Agents; Ceftriaxone; Cephalosporins; Child; Child, Preschool; Drug Therapy, Combination; Female; Fluoroquinolones; Humans; Infant; Infusions, Intravenous; Liver; Male; Meningitis, Bacterial; Naphthyridines; Seizures; Treatment Outcome | 2002 |
13 other study(ies) available for trovafloxacin and ro13-9904
| Article | Year |
|---|---|
Evaluation of CP-99,219, a new fluoroquinolone, for treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis.
Topics: Animals; Anti-Infective Agents; Ceftriaxone; Cephalosporin Resistance; Colony Count, Microbial; Dexamethasone; Drug Evaluation; Drug Therapy, Combination; Fluoroquinolones; Humans; Meningitis, Pneumococcal; Microbial Sensitivity Tests; Naphthyridines; Penicillin Resistance; Rabbits; Streptococcus pneumoniae; Vancomycin | 1995 |
Trovafloxacin in treatment of rabbits with experimental meningitis caused by high-level penicillin-resistant Streptococcus pneumoniae.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Ceftriaxone; Fluoroquinolones; Meningitis, Pneumococcal; Microbial Sensitivity Tests; Naphthyridines; Penicillin Resistance; Rabbits; Rifampin; Streptococcus pneumoniae | 1997 |
Trovafloxacin delays the antibiotic-induced inflammatory response in experimental pneumococcal meningitis.
Topics: Adult; Animals; Anti-Infective Agents; Ceftriaxone; Cephalosporins; Disease Models, Animal; Fluoroquinolones; Humans; Injections, Intravenous; Interleukin-1; Lactic Acid; Meningitis, Pneumococcal; Naphthyridines; Rabbits; Streptococcus pneumoniae; Tumor Necrosis Factor-alpha | 1997 |
Synergistic activity of trovafloxacin and ceftriaxone or vancomycin against Streptococcus pneumoniae with various penicillin susceptibilities.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ceftriaxone; Cephalosporins; Drug Synergism; Fluoroquinolones; Humans; Naphthyridines; Penicillin Resistance; Streptococcal Infections; Streptococcus pneumoniae; Vancomycin | 1998 |
Ethanol feeding does not affect the efficacy or pharmacokinetics of azithromycin, trovafloxacin, or ceftriaxone in a rat model of pneumococcal pneumonia.
Topics: Animals; Anti-Infective Agents; Azithromycin; Bronchoalveolar Lavage Fluid; Ceftriaxone; Disease Models, Animal; Ethanol; Feeding Behavior; Fluoroquinolones; Leukocyte Count; Male; Naphthyridines; Neutrophils; Pneumonia, Pneumococcal; Rats; Rats, Sprague-Dawley | 1999 |
Anti-pneumococcal activity of gatifloxacin compared with other quinolone and non-quinolone agents.
Topics: Amoxicillin; Anti-Infective Agents; Ceftriaxone; Cefuroxime; Cephalosporins; Ciprofloxacin; Clarithromycin; Fluoroquinolones; Gatifloxacin; Levofloxacin; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin; Penicillin Resistance; Streptococcus pneumoniae | 1999 |
Lower lipoteichoic and teichoic acid CSF concentrations during treatment of pneumococcal meningitis with non-bacteriolytic antibiotics than with ceftriaxone.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Ceftriaxone; Cephalosporins; Disease Models, Animal; Fluoroquinolones; Immunoenzyme Techniques; Lipopolysaccharides; Meningitis, Pneumococcal; Moxifloxacin; Naphthyridines; Polysaccharides, Bacterial; Quinolines; Rabbits; Reference Values; Rifabutin; Teichoic Acids; Virginiamycin | 1999 |
Synergy between trovafloxacin and ceftriaxone against penicillin-resistant pneumococci in the rabbit meningitis model and in vitro.
Topics: Animals; Anti-Infective Agents; Ceftriaxone; Cephalosporins; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Fluoroquinolones; Meningitis, Pneumococcal; Microbial Sensitivity Tests; Naphthyridines; Penicillin Resistance; Pneumococcal Infections; Rabbits; Streptococcus pneumoniae | 2000 |
The effect of three broad-spectrum antimicrobials on mononuclear cell responses to encapsulated bacteria: evidence for down-regulation of cytokine mRNA transcription by trovafloxacin.
Topics: Animals; Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; Cytokines; Fluoroquinolones; Humans; Leukocytes, Mononuclear; Lipopolysaccharides; Mice; Mice, Inbred C57BL; Naphthyridines; RNA, Messenger; Teichoic Acids | 2000 |
Comparative study of treatment with penicillin, ceftriaxone, trovafloxacin, quinupristin-dalfopristin and vancomycin in experimental endocarditis due to penicillin- and ceftriaxone-resistant Streptococcus pneumoniae.
Topics: Animals; Anti-Infective Agents; Ceftriaxone; Disease Models, Animal; Drug Resistance, Multiple; Endocarditis, Bacterial; Fluoroquinolones; Humans; Male; Naphthyridines; Penicillin Resistance; Penicillins; Pneumococcal Infections; Rabbits; Streptococcus pneumoniae; Vancomycin; Virginiamycin | 2001 |
The efficacy of trovafloxacin versus ceftriaxone in the treatment of experimental brain abscess/cerebritis in the rat.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Area Under Curve; Brain Abscess; Ceftriaxone; Disease Models, Animal; Female; Fluoroquinolones; Half-Life; Injections, Subcutaneous; Microbial Sensitivity Tests; Naphthyridines; Rats; Rats, Wistar; Staphylococcal Infections; Staphylococcus aureus | 2003 |
Effect of cirrhosis on antibiotic efficacy in a rat model of pneumococcal pneumonia.
Topics: Animals; Azithromycin; Biological Availability; Blood Chemical Analysis; Bronchoalveolar Lavage Fluid; Ceftriaxone; Disease Models, Animal; Drug Therapy, Combination; Fluoroquinolones; Injections, Subcutaneous; Liver Cirrhosis; Male; Naphthyridines; Pneumonia, Pneumococcal; Random Allocation; Rats; Rats, Sprague-Dawley; Reference Values; Risk Assessment; Sensitivity and Specificity; Survival Rate | 2005 |
Pfizer settles with victims of Nigerian drug trial.
Topics: Anti-Infective Agents; Ceftriaxone; Child; Clinical Trials as Topic; Developing Countries; Drug Industry; Fluoroquinolones; Humans; Meningitis; Naphthyridines; Nigeria; Scientific Misconduct | 2011 |